# The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma

> **NCT05576571** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Serum Tumor Markers

## Interventions

- **DIAGNOSTIC_TEST:** Met-score

## Key facts

- **NCT ID:** NCT05576571
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-16
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05576571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05576571, "The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05576571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*